InvestorsHub Logo

dukesking

11/21/20 9:33 AM

#311118 RE: jessellivermore #311111

JL, thanks for the tip on EXROF. It looks very interesting.

north40000

11/21/20 3:42 PM

#311173 RE: jessellivermore #311111

JL, Amarin announced (August 7, 2020) that it is supporting a large trial of Vascepa in treating patients afflicted with COVID-19; P-I is Kaiser-Permanente. JT and CG have elaborated on that topic by noting AMRN is supporting 3 randomized, blinded trials of Vascepa in ~ 3500 patients in the United States, Canada and Argentina. See Amarin’s earnings call, 11/05/2020.

Reasons correspond to those you advance.

xblkbk

11/21/20 7:36 PM

#311198 RE: jessellivermore #311111

Thanks JL!!

Hope all is well with you. Glad to see you are still involved in AMRN. I added a bunch more under $4. Happy Holidays.